Navigation Links
Long-Term Statin Use Won't Up Cancer Risk: Study
Date:11/18/2010

By Amanda Gardner
HealthDay Reporter

THURSDAY, Nov. 18 (HealthDay News) -- New research supports the notion that patients who take cholesterol-lowering drugs known as statins may not have an increased risk for cancer, as some previous studies suggested.

Statins are the most commonly prescribed drugs for people with high blood cholesterol levels, which are linked to heart disease. Brand names include Crestor, Lipitor and Zocor.

"Three or four years ago there was a flare of articles pointing out that statins could produce cancer, and, at present, the most recent studies do not show this, and this is one of them," said Dr. Valentin Fuster, past president of the American Heart Association and director of Mount Sinai Heart in New York City.

This latest study, slated for presentation Wednesday at the annual meeting of the American Heart Association in Chicago, was conducted by researchers from S2 Statistical Solutions, Inc., a company that does economic research for health care-related businesses; the University of California, San Diego; and GE Healthcare, a division of General Electric, which provided the database for the study.

Another recent study, reported Nov. 10 at a meeting of the American Association for Cancer Research, also found that long-term use of statins did not increase the risk of cancer and might even decrease users' risks for lymphoma, melanoma and endometrial tumors.

But while research showed that short-term use of statins had little effect on the risk of developing cancer, less was known about their long-term use.

To get a clearer picture over time, the authors of this new study pored through more than 11 million patient records over two decades (1990 to early 2009) to identify almost 46,000 comparable pairs of statin and non-statin users.

The pairs were followed for an average of eight years.

Cancer occurred in 11.4 percent of almost 24,000 patients during th
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Battlefield camaraderie yields long-term dividends for veterans, study finds
2. Newer cornea transplant surgery shows short- and long-term promise
3. Proton beam therapy shows encouraging long-term outcome for patients with locally advanced sinonasal cancers
4. Clinton Bush Haiti Fund Awards International Medical Corps $500,000 for Emergency Medical Care and Long-Term Rebuilding
5. Quantity vs. quality: Long-term use of bone-building osteoporosis drugs
6. Options to Integrate Health and Long-Term Care for Dual Eligibles
7. Long-Term Use of Osteoporosis Drugs Linked to Fractures
8. Plaque on CT scan is strong predictor of heart disease, worse long-term outcomes
9. Increased radiation dose does not increase long-term side effects for prostate cancer patients
10. Health Care Reform Bill Will Also Improve Long-Term Care
11. Long-Term Breast-Feeding Tied to More Aggressive Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Long-Term Statin Use Won't Up Cancer Risk: Study
(Date:9/19/2014)... Mozes HealthDay Reporter ... burdened by stress and family conflicts before surgery may ... a new study suggests. Investigators found that patients ... nearly three times greater risk for complications compared to ... "We,ve long known that patient quality of life ...
(Date:9/19/2014)... cells to treat and cure disease is a ... hindered by the inability of doctors and scientists to ... cells in patients without resorting to invasive procedures, like ... in the online journal Magnetic Resonance in Medicine ... School of Medicine, University of Pittsburgh and elsewhere describe ...
(Date:9/19/2014)... CHICAGO --- Domestic violence occurs at least as ... couples compared to opposite-sex couples, according to a ... , Previous studies, when analyzed together, indicate ... percent of lesbian, gay and bisexual individuals. However, ... abuse paints an incomplete picture of the true ...
(Date:9/19/2014)... NY (PRWEB) September 20, 2014 As summer ... Krishnan DMD in Queens, NY now reminds area patients about ... than 80% of our population affected by gum disease, there ... longer.” , For over 20 years Dr. Krishnan has treated ... Hills office location. “Most patients that come in due to ...
(Date:9/19/2014)... 19, 2014) Shahram Majidi, M.D., a second-year ... George Washington University School of Medicine and Health ... Heart Association to study the presence of diffuse ... hemorrhage (ICH). , "According to epidemiological studies, intracerebral ... all strokes, but is the least treatable form ...
Breaking Medicine News(10 mins):Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 2Health News:Family Squabbles Can Derail Recovery From Cancer Surgery 3Health News:A better way to track emerging cell therapies using MRIs 2Health News:Domestic violence likely more frequent for same-sex couples 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 2Health News:New York Periodontist Dr. Prabha Krishnan Now Raises Awareness about the Dangers of Untreated Decay, Gingivitis and Gum Disease During Self-Awareness Month 3Health News:GW researcher receives grant to study brain swelling following bleeding in the brain 2
... Indonesia's resort island of Bali, health officials have culled ... to Bali from the adjacent Java Island, reported Anak ... than 24 bird flu related deaths have been reported ... to the above situation, import of poultry and livestock ...
... by Dr. Martina Stippler it was found that magnesium levels ... A team at the University Of Pittsburgh Brain Trauma Research ... severe brain injuries. The study results were presented at the ... San Francisco. ,The results show that 35 of ...
... demanding the government for new and better breast cancer drugs. ... for Clinical Excellence rejected two new breast cancer drugs for ... groups who were campaigning for access to every new drug ... in clinical trials. The two drugs were docetaxel and paclitaxel. ...
... County Hospital (RHCH) in Winchester, which is already suffering from ... spending ?359,000 caring// for two patients even though they do ... hospital for two years even though they do not need ... since April 2004, the so called "bed blockers", have not ...
... defended the hike in salaries offered to GPs after negative ... claiming //that the wage hikes were responsible for NHS deficits. ... and since then salaries have increased by 25 percent. BMA's ... sensational headlines over the pay being as much as ?100,000 ...
... the cancers that results in death among the Britons. ... a tablet// called Xeloda have only been given to ... Institute of Health and Clinical Excellence (NICE) issued guidance ... who had cancerous tissue removed at an early stage. ...
Cached Medicine News:Health News:Hospitals Facing Huge Losses From Healthy Patients Yet To Discharge 2
(Date:9/19/2014)... , September 19, 2014 ... Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture ... Users (Hospitals), Advanced technologies - Global Forecast to ... is poised to reach $19,786.3 Million by 2019 ... of 6.8% from 2014 to 2019. ...
(Date:9/19/2014)... , Sept. 19, 2014 Merck (NYSE: MRK ... and Canada , is teaming with celebrity ... Diabetes: Logra Tus Metas , an educational program encouraging Hispanics with ... -- a key treatment goal to help reduce the risk of ... are at a higher risk for developing type 2 diabetes ...
(Date:9/19/2014)... WOONSOCKET, R.I. , Sept. 19, 2014 Five MinuteClinic ... Memphis metropolitan area. Three clinics opened in ... earlier this month. A fourth clinic will be added in ... in Bartlett is expected to open October ... medical clinics in the United States . ...
Breaking Medicine Technology:Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5MinuteClinic Walk-in Medical Clinics Opening in Memphis 2MinuteClinic Walk-in Medical Clinics Opening in Memphis 3
... Hana,Biosciences (Nasdaq: HNAB ) today announced ... a planned, pre-specified safety review of interim,data from ... (vincristine,sulfate liposomes injection) for the treatment of adult ... results of the IDMC review continue to,support the ...
... Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium ... today positive preliminary results from its Phase II ... prednisone (D/P) in men with docetaxel refractory, castrate ... of Clinical Oncology (ASCO) Genitourinary Cancers Symposium in ...
Cached Medicine Technology:Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound 2Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound 3Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound 4Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound 5Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer 2Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer 3Ascenta Therapeutics Announces Positive Preliminary Results with AT-101 in Docetaxel Refractory Prostate Cancer 4
...
...
Medtronic neurosurgery external drainage and monitoring (EDM) products meet a variety of needs for CSF drainage and monitoring....
Monitorr ICP external CSF drainage system with self-contained ICP setting....
Medicine Products: